Sidani Souraya, Epstein Dana R, Fox Mary
Professor and Research Chair, School of Nursing, Ryerson University, Toronto, Ontario, Canada.
Research Professor, College of Health Solutions, Arizona State University, Research Associate, Phoenix Veterans Affairs Health Care System, Phoenix, Arizona.
Res Nurs Health. 2017 Oct;40(5):459-469. doi: 10.1002/nur.21808. Epub 2017 Aug 31.
Treatment satisfaction is recognized as an essential aspect in the evaluation of an intervention's effectiveness, but there is no measure that provides for its comprehensive assessment with regard to behavioral interventions. Informed by a conceptualization generated from a literature review, we developed a measure that covers several domains of satisfaction with behavioral interventions. In this paper, we briefly review its conceptualization and describe the Multi-Dimensional Treatment Satisfaction Measure (MDTSM) subscales. Satisfaction refers to the appraisal of the treatment's process and outcome attributes. The MDTSM has 11 subscales assessing treatment process and outcome attributes: treatment components' suitability and utility, attitude toward treatment, desire for continued treatment use, therapist competence and interpersonal style, format and dose, perceived benefits of the health problem and everyday functioning, discomfort, and attribution of outcomes to treatment. The MDTSM was completed by persons (N = 213) in the intervention group in a large trial of a multi-component behavioral intervention for insomnia within 1 week following treatment completion. The MDTSM's subscales demonstrated internal consistency reliability (α: .65 - .93) and validity (correlated with self-reported adherence and perceived insomnia severity at post-test). The MDTSM subscales can be used to assess satisfaction with behavioral interventions and point to aspects of treatments that are viewed favorably or unfavorably.
治疗满意度被认为是评估干预措施有效性的一个重要方面,但目前尚无一种措施能够全面评估行为干预的治疗满意度。基于文献综述得出的概念框架,我们开发了一种涵盖行为干预多个满意度领域的测量方法。在本文中,我们简要回顾其概念框架,并描述多维治疗满意度量表(MDTSM)的各个子量表。满意度是指对治疗过程和结果属性的评价。MDTSM有11个子量表,用于评估治疗过程和结果属性:治疗组成部分的适宜性和效用、对治疗的态度、继续使用治疗的意愿、治疗师的能力和人际风格、形式和剂量、健康问题和日常功能的感知益处、不适感以及结果归因于治疗。在一项针对失眠的多成分行为干预大型试验中,干预组的213名参与者在治疗结束后1周内完成了MDTSM。MDTSM的子量表显示出内部一致性信度(α:0.65 - 0.93)和效度(与测试后自我报告的依从性和感知到的失眠严重程度相关)。MDTSM子量表可用于评估对行为干预的满意度,并指出治疗中被看好或不被看好的方面。